Lipopolysaccharide dependent cellular activation.
Tobias
P S
PS
Department of Immunology, IMM-12, Scripps Research Institute, La Jolla, CA 92037, USA.
Gegner
J
J
Tapping
R
R
Orr
S
S
Mathison
J
J
Lee
J D
JD
Kravchenko
V
V
Han
J
J
Ulevitch
R J
RJ
D000209:Acute-Phase Proteins; D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism; D016207:Cytokines / Q000096:biosynthesis; D004727:Endothelium / Q000166:cytology; D019446:Endotoxemia / Q000276:immunology; D006801:Humans; D007295:Inositol Phosphates / Q000378:metabolism; D018950:Lipopolysaccharide Receptors / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors / Q000276:immunology* / Q000378:metabolism / Q000494:pharmacology; D008262:Macrophage Activation / Q000187:drug effects; D008562:Membrane Glycoproteins; D011485:Protein Binding; D015398:Signal Transduction; D013268:Stimulation, Chemical; D015533:Transcriptional Activation / Q000187:drug effects; D000099231:Lipopolysaccharide-Binding Protein
D000209:Acute-Phase Proteins; D001798:Blood Proteins; D002352:Carrier Proteins; D016207:Cytokines; D007295:Inositol Phosphates; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D008562:Membrane Glycoproteins; D000099231:Lipopolysaccharide-Binding Protein; C014575:glycerylphosphoinositol